Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Coleman
C N
CN
Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA 02115.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007375:Interleukin-1 / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy*; D009593:Nitroimidazoles / Q000378:metabolism / Q000627:therapeutic use; D010084:Oxidation-Reduction; D010100:Oxygen / Q000627:therapeutic use; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents
D000970:Antineoplastic Agents; D007375:Interleukin-1; D009593:Nitroimidazoles; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D001973:Bromodeoxyuridine; D005978:Glutathione; D007065:Idoxuridine; D010100:Oxygen